Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cryptococcosis.

Methee Chayakulkeeree1, John R Perfect

  • 1Department of Medicine, Division of Infectious Diseases and International Health, Duke University Medical Center, P.O. Box 3353, Durham, NC 27710, USA.

Infectious Disease Clinics of North America
|September 21, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

WHO Global Antimicrobial Resistance Surveillance System (GLASS) for monitoring bloodstream infections due to <i>Candida</i>: findings from a demonstration study.

EClinicalMedicine·2026
Same author

Ensitrelvir for the treatment of hospitalized adults with COVID-19: an international phase 3 randomized placebo-controlled trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Closing the gap on antifungal resistance.

Nature medicine·2026
Same author

A breakthrough invasive <i>Aspergillus granulosus</i> infection following azole antifungal therapy in a patient with primary myelofibrosis: case report.

Medical mycology case reports·2026
Same author

Multisystem <i>Lomentospora prolificans</i> progression on fosmanogepix despite <i>in vitro</i> activity: a call for expanding clinical research on novel antifungals.

ASM case reports·2026
Same author

Evaluating long-read metagenomics for bloodstream infection diagnostics: a pilot study from a Thai Tertiary Hospital.

Scientific reports·2026
Same journal

Prevention and Control of Clostridioides difficile Infection for the Infectious Diseases Clinician.

Infectious disease clinics of North America·2026
Same journal

Infection Control Strategies to Prevent Emergence and Transmission of Resistant Gram-Negative Bacteria.

Infectious disease clinics of North America·2026
Same journal

Preventing the Spread of Tuberculosis in Health Care Settings.

Infectious disease clinics of North America·2026
Same journal

Threats to Success: Principles of Infection Prevention and Control in Health Care Settings, Part 2: Device and Pathogen Management.

Infectious disease clinics of North America·2026
Same journal

Ventilator-Associated Events: Surveillance and Prevention.

Infectious disease clinics of North America·2026
Same journal

Nosocomial Fungal Infections: Epidemiology, Control Strategies, and Prevention of Candida and Other Yeasts.

Infectious disease clinics of North America·2026
See all related articles

Cryptococcus is a significant fungal pathogen causing infections in immunocompromised and immunocompetent individuals. This review covers cryptococcal infections, including classification, epidemiology, pathogenesis, and clinical aspects.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Molecular Pathogenesis

Background:

  • Cryptococcus species, particularly Cryptococcus neoformans and Cryptococcus gattii, have gained significant clinical importance over the past two decades.
  • These yeasts are recognized as major primary and secondary pathogens affecting both immunocompromised and immunocompetent hosts.
  • The increasing population of immunocompromised individuals due to HIV, organ transplantation, and immunosuppressive therapies has led to cryptococcal infections becoming a notable complication in modern medicine.

Purpose of the Study:

  • To provide a comprehensive overview of current issues in cryptococcal infections.
  • To examine recent advancements in the classification, epidemiology, and pathogenesis of Cryptococcus.
  • To discuss specific clinical aspects and management strategies for cryptococcal infections.

Related Experiment Videos

Main Methods:

  • Literature review of recent studies on Cryptococcus.
  • Analysis of epidemiological data and outbreak reports.
  • Synthesis of information on molecular pathogenesis and clinical manifestations.

Main Results:

  • Cryptococcus neoformans and Cryptococcus gattii are significant pathogens with evolving epidemiology.
  • A recent outbreak of C. gattii highlighted its pathogenicity and clinical importance.
  • The fungus is an established infectious complication in patients undergoing modern medical treatments that induce immunosuppression.

Conclusions:

  • Cryptococcal infections remain a critical concern in clinical practice.
  • Understanding the updated classification, epidemiology, and pathogenesis is essential for effective management.
  • Further research into the molecular mechanisms and clinical presentations will aid in combating these infections.